Conditions: Diabetes
Keywords: Diabetes
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 43
Healthy volunteers: no

Brief summary:
In this study the investigators would like to test the hypothesis that in diabetic patients discharged from the hospital, SoloSTAR Glargine insulin will be superior to syringe-injected Glargine in terms of diabetes control, compliance, and patient satisfaction and preference. The investigators will test this hypothesis in a randomized, crossover trial.

Detailed description:

Arms:
arm 1: SoloSTAR pen-administered Glargine insulin then syringe-administered Glargine insulin arm 2: Syringe-administered Glargine insulin and then pen-administered Glargine insulin

Interventions: intervention 1: Glargine insulin
Intervention descriptions: intervention 1: 20-180 units per day

Protocol document: